h-header

news

News dal mondo

08

Lug

HHS OIG criticizes US FDA’s foreign inspection program in new report

The US Department of Health and Human Services’ Office of Inspector General (OIG) asserted in a new report that the US Food and Drug Administration’s (FDA) practice of preannouncing foreign inspections, inadequate documentation of investigator training and its slow pace at issuing warning compromise the agency’s foreign inspections program....[FDA - RAPS]

24

Set

FDA: Hope for user fee reauthorization

While the US Food and Drug Administration has warned that it would need to lay off staff in the first...

23

Set

Farmaci biosimilari in Italia: report AIFA aggiornati a maggio 2022

L’Agenzia pubblica i report sul monitoraggio dei farmaci biosimilari in Italia, aggiornati ad maggio 2022. Oltre...

23

Set

Impact Factors for Sourcing

How is current market volatility, led by inflationary pressures, supply-chain disruptions, and geopolitical...

22

Set

AIFA - Synchron Research Service: il riesame conferma la sospensione di medicinali a causa di irregolarità negli studi

Il Comitato per i medicinali per uso umano (CHMP) dell'EMA ha confermato la propria raccomandazione...

slider-banner

h-footer